Drug-induced liver disease accounts for about 50% of acute or subacute liver failure in the United States. United Network of Organ Sharing (UNOS) data suggest 8%-20% of liver transplantation in this country per year is for fulminant liver failure due to drugs. Even though the most common medication
Efavirenz induced acute liver failure requiring liver transplantation in a slow drug metaboliser
β Scribed by Elsharkawy, Ahmed M.; Schwab, Ulrich; McCarron, Brendan; Burt, Alastair D.; Daly, Ann K.; Hudson, Mark; Masson, Steven
- Book ID
- 123170778
- Publisher
- Elsevier Science
- Year
- 2013
- Tongue
- English
- Weight
- 472 KB
- Volume
- 58
- Category
- Article
- ISSN
- 1386-6532
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Studies of acute liver failure from drugs have included cases mostly attributed to acetaminophen (APAP) but have reported limited data on other drugs. We used the United Network for Organ Sharing (UNOS) liver transplant database from 1990 to 2002 to identify recipients and estimate a U.S. population
Once defined clinical criteria are fulfilled in acetaminophen-induced hepatotoxicity, prognosis without orthotopic liver transplantation (OLT) may be very poor. In the present study, we examined the application and outcome of OLT in 548 patients admitted to a single center between 1990 and 1996. Fou
The majority of patients with acute liver failure (ALF) die waiting for orthotopic liver transplantation (OLT). No other treatment modality is shown to improve survival. This study was conducted to assess the safety and feasibility of hepatocyte transplantation (HT) and subsequent engraftment and fu